Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wilczek, Ewa ^a   Szparecki, Grzegorz ^a   Lukasik, Dominika ^a   Koperski, Lukasz ^a   Winiarska, Magdalena ^a   Wilczynski, Grzegorz M ^b   Wasiutynski, Aleksander ^a   Gornicka, Barbara ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; ORPHAN NUCLEAR RECEPTOR; PROTEIN VARIANT; SMALL HETERODIMER PARTNER PROTEIN; UNCLASSIFIED DRUG; CELL RECEPTOR; NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; MALE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ADOLESCENT; COHORT ANALYSIS; FIBROLAMELLAR HEPATOCELLULAR CARCINOMA; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, CYTOPLASMIC AND NUCLEAR; YOUNG ADULT;

EID: 84856090070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030944     Document Type: Article

References (18)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2008) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-917.
2. Farazi PA, DePinho RA, (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687.
3. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, et al. (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390.
4. McKenna NJ, O'Malley BW, (2010) SnapShot: Nuclear receptors I. Cell 142: 822-822 e821.
5. Lee HK, Lee YK, Park SH, Kim YS, Park SH, et al. (1998) Structure and expression of the orphan nuclear receptor SHP gene. J Biol Chem 273: 14398-14402.
6. Bavner A, Sanyal S, Gustafsson JA, Treuter E, (2005) Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol Metab 16: 478-488.
7. Zhang Y, Soto J, Park K, Viswanath G, Kuwada S, et al. (2010) Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol Cell Biol 30: 1341-1356.
8. Zhang Y, Xu P, Park K, Choi Y, Moore DD, et al. (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48: 289-298.
9. Dehm SM, Tindall DJ, (2006) Molecular regulation of androgen action in prostate cancer. J Cell Biochem 99: 333-344.
10. Aupperlee M, Kariagina A, Osuch J, Haslam SZ, (2005) Progestins and breast cancer. Breast Dis 24: 37-57.
11. Auwerx J, (2002) Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain? Am J Physiol Gastrointest Liver Physiol 282: G581-585.
12. Nemenoff RA, Winn RA, (2005) Role of nuclear receptors in lung tumourigenesis. Eur J Cancer 41: 2561-2568.
13. He N, Park K, Zhang Y, Huang J, Lu S, et al. (2008) Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth. Gastroenterology 134: 793-802.
14. Kim K, Kim KH, Cho HK, Kim HY, Kim HH, et al. (2010) SHP (small heterodimer partner) suppresses the transcriptional activity and nuclear localization of Hedgehog signalling protein Gli1. Biochem J 427: 413-422.
15. Inamoto T, Czerniak BA, Dinney CP, Kamat AM, (2010) Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer. Cancer 116: 340-346.
16. Kakar S, Burgart LJ, Batts KP, Garcia J, Jain D, et al. (2005) Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol 18: 1417-1423.
17. Maniaci V, Davidson BR, Rolles K, Dhillon AP, Hackshaw A, et al. (2009) Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy. Eur J Surg Oncol 35: 617-621.
18. Park YY, Choi HS, Lee JS, (2010) Systems-level analysis of gene expression data revealed NR0B2/SHP as potential tumor suppressor in human liver cancer. Mol Cells 30: 485-491.